Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  hu14.18-IL2 fusion protein
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Ex-Vivo Expanded and Activated Donor NK Cells and Hu14.18-IL2 in Treating Patients with Relapsed or Refractory Neuroblastoma
Status: Not yet active
Phase: Phase I
Type: Treatment
Age: 7 months to 21 years
Trial IDs: UW16009, NCI-2017-01267, NCT03209869
Start Over